{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:40:32Z","timestamp":1792525232004,"version":"4.5.0"},"reference-count":136,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Purinergic Signalling"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11302-026-10194-y","type":"journal-article","created":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T03:03:40Z","timestamp":1792465420000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Circadian regulation of the S1PR1\u2013P2X7 signalling axis in obesity-associated metabolic inflammation: molecular crosstalk and therapeutic perspectives"],"prefix":"10.1007","volume":"22","author":[{"given":"Alka","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parag","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hina","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,20]]},"reference":[{"key":"10194_CR1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3390\/ONCO6030031","volume":"6","author":"N Baxevanis","year":"2026","unstructured":"Baxevanis N, Dutta G, Mishra P, Mishra SP, Badhai J (2026) Obesity as a whole-body regulatory disorder: a systems biology framework for metaflammation, accelerated aging, and colorectal cancer risk. Onco 6:31. https:\/\/doi.org\/10.3390\/ONCO6030031","journal-title":"Onco"},{"key":"10194_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS26199715","volume":"26","author":"W Choi","year":"2025","unstructured":"Choi W, Woo GH, Kwon TH, Jeon JH (2025) Obesity-driven metabolic disorders: the interplay of inflammation and mitochondrial dysfunction. Int J Mol Sci 26:9715. https:\/\/doi.org\/10.3390\/IJMS26199715","journal-title":"Int J Mol Sci"},{"key":"10194_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/S44324-024-00030-5","volume":"2","author":"I Caruso","year":"2024","unstructured":"Caruso I, Cignarelli A, Sorice GP, Perrini S, Giorgino F (2024) Incretin-based therapies for the treatment of obesity-related diseases. NPJ Metab Health Dis 2:31. https:\/\/doi.org\/10.1038\/S44324-024-00030-5","journal-title":"NPJ Metab Health Dis"},{"key":"10194_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS27062539","volume":"27","author":"M Nicze","year":"2026","unstructured":"Nicze M, Bor\u00f3wka M, Dec A, Bu\u0142dak \u0141, Bo\u0142dys A, Okopie\u0144 B (2026) Resistant and refractory obesity: the complexity of anti-obesity therapy failure. Int J Mol Sci 27:2539. https:\/\/doi.org\/10.3390\/IJMS27062539","journal-title":"Int J Mol Sci"},{"key":"10194_CR5","doi-asserted-by":"publisher","unstructured":"Hammad M, Shakoor K (2026) Circadian rhythm modulation in metabolic disease: targeting clock genes for obesity and insulin resistance. Open Exploration 2019 3:101467-.\u00a0https:\/\/doi.org\/10.37349\/EEMD.2026.101467","DOI":"10.37349\/EEMD.2026.101467"},{"key":"10194_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS25020932","author":"K Kajita","year":"2024","unstructured":"Kajita K, Ishii I, Mori I, Asano M, Fuwa M, Morita H (2024) Sphingosine 1-phosphate regulates obesity and glucose homeostasis. Int J Mol Sci. https:\/\/doi.org\/10.3390\/IJMS25020932","journal-title":"Int J Mol Sci"},{"key":"10194_CR7","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/J.KINT.2024.10.024","volume":"107","author":"M Amini","year":"2025","unstructured":"Amini M, Frisch J, Jost P, Sarakpi T, Selejan SR, Becker E et al (2025) Purinergic receptor P2X7 regulates interleukin-1\u03b1 mediated inflammation in chronic kidney disease in a reactive oxygen species-dependent manner. Kidney Int 107:457\u2013475. https:\/\/doi.org\/10.1016\/J.KINT.2024.10.024","journal-title":"Kidney Int"},{"key":"10194_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/CELLS9071682","volume":"9","author":"J Guitton","year":"2020","unstructured":"Guitton J, Bandet CL, Mariko ML, Tan-Chen S, Bourron O, Benomar Y et al (2020) Sphingosine-1-phosphate metabolism in the regulation of obesity\/type 2 diabetes. Cells 9:1682. https:\/\/doi.org\/10.3390\/CELLS9071682","journal-title":"Cells"},{"key":"10194_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/J.BBI.2026.106548","volume":"136","author":"IKY Chat","year":"2026","unstructured":"Chat IKY, Hansson LS, Lekander M, Jacobsen C, Benson S, Hebebrand J et al (2026) Obesity, low-grade inflammation, and inflammatory response to immune challenge modulate willingness to expend effort for reward. Brain Behav Immun 136:106548. https:\/\/doi.org\/10.1016\/J.BBI.2026.106548","journal-title":"Brain Behav Immun"},{"key":"10194_CR10","doi-asserted-by":"publisher","first-page":"22193","DOI":"10.1074\/JBC.M113.477786","volume":"288","author":"JS Ross","year":"2013","unstructured":"Ross JS, Hu W, Rosen B, Snider AJ, Obeid LM, Cowart LA (2013) Sphingosine kinase 1 is regulated by peroxisome proliferator-activated receptor \u03b1 in response to free fatty acids and is essential for skeletal muscle interleukin-6 production and signaling in diet-induced obesity. J Biol Chem 288:22193\u201322206. https:\/\/doi.org\/10.1074\/JBC.M113.477786","journal-title":"J Biol Chem"},{"key":"10194_CR11","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.2337\/DB11-1389\/-\/DC1","volume":"61","author":"S Sun","year":"2012","unstructured":"Sun S, Xia S, Ji Y, Kersten S, Qi L (2012) The ATP-P2X 7 signaling axis is dispensable for obesity-associated inflammasome activation in adipose tissue. Diabetes 61:1471\u20131478. https:\/\/doi.org\/10.2337\/DB11-1389\/-\/DC1","journal-title":"Diabetes"},{"key":"10194_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS22063254","volume":"22","author":"G Jorquera","year":"2021","unstructured":"Jorquera G, Russell J, Monsalves-\u00e1lvarez M, Cruz G, Valladares-Ide D, Basualto-Alarc\u00f3n C et al (2021) NLRP3 inflammasome: potential role in obesity related low-grade inflammation and insulin resistance in skeletal muscle. Int J Mol Sci 22:3254. https:\/\/doi.org\/10.3390\/IJMS22063254","journal-title":"Int J Mol Sci"},{"key":"10194_CR13","doi-asserted-by":"publisher","first-page":"343","DOI":"10.3390\/IJMS20020343","volume":"20","author":"M Astiz","year":"2019","unstructured":"Astiz M, Heyde I, Oster H (2019) Mechanisms of communication in the mammalian circadian timing system. Int J Mol Sci 20:343. https:\/\/doi.org\/10.3390\/IJMS20020343","journal-title":"Int J Mol Sci"},{"key":"10194_CR14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/J.ALCOHOL.2026.07.002","volume":"135","author":"J Herrera","year":"2026","unstructured":"Herrera J, Button M, Doherty-Haigh P, Szubinski A, Amir S, Schoettner K (2026) Circadian clock genes Bmal1 and Per2 in the nucleus accumbens are negative regulators of alcohol-drinking behavior in mice. Alcohol 135:47\u201356. https:\/\/doi.org\/10.1016\/J.ALCOHOL.2026.07.002","journal-title":"Alcohol"},{"key":"10194_CR15","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1210\/ENDREV\/BNAA014","volume":"41","author":"YH Kim","year":"2020","unstructured":"Kim YH, Lazar MA (2020) Transcriptional control of circadian rhythms and metabolism: a matter of time and space. Endocr Rev 41:707. https:\/\/doi.org\/10.1210\/ENDREV\/BNAA014","journal-title":"Endocr Rev"},{"issue":"1","key":"10194_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/S43088-022-00290-4","volume":"11","author":"N Fatima","year":"2022","unstructured":"Fatima N, Sonkar GK, Singh S (2022) Circadian mechanism disruption is associated with dysregulation of inflammatory and immune responses: a systematic review. Beni-Suef Univ J Basic Appl Sci 11(1):107. https:\/\/doi.org\/10.1186\/S43088-022-00290-4","journal-title":"Beni-Suef Univ J Basic Appl Sci"},{"key":"10194_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/FPHYS.2025.1553736","volume":"16","author":"OC Baltatu","year":"2025","unstructured":"Baltatu OC, Campos LA, Cipolla-Neto J (2025) Circadian system coordination: new perspectives beyond classical models. Front Physiol 16:1553736. https:\/\/doi.org\/10.3389\/FPHYS.2025.1553736","journal-title":"Front Physiol"},{"key":"10194_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/FENDO.2022.915139","volume":"13","author":"W Zhang","year":"2022","unstructured":"Zhang W, Xiong Y, Tao R, Panayi AC, Mi B, Liu G (2022) Emerging insight into the role of circadian clock gene BMAL1 in cellular senescence. Front Endocrinol (Lausanne) 13:915139. https:\/\/doi.org\/10.3389\/FENDO.2022.915139","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"10194_CR19","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41413-025-00403-6","volume":"13","author":"Y Ze","year":"2025","unstructured":"Ze Y, Wu Y, Tan Z, Li R, Li R, Gao W et al (2025) Signaling pathway mechanisms of circadian clock gene Bmal1 regulating bone and cartilage metabolism: a review. Bone Res 13(1):19. https:\/\/doi.org\/10.1038\/s41413-025-00403-6","journal-title":"Bone Res"},{"key":"10194_CR20","doi-asserted-by":"publisher","unstructured":"Li R, Gao Q, Huang Y, Pan J-A, Du L, Peng X (2026) The PER gene family: pivotal regulators bridging circadian clock disruption to multifactorial pathologies. EMJ Flagship J 112 11:128\u201340. https:\/\/doi.org\/10.33590\/EMJ\/V98IW0SO","DOI":"10.33590\/EMJ\/V98IW0SO"},{"key":"10194_CR21","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3389\/FENDO.2014.00049","volume":"5","author":"G Griebel","year":"2014","unstructured":"Griebel G, Ravinet-Trillou C, Beesk\u00e9 S, Avenet P, Pichat P (2014) Mice deficient in cryptochrome 1 (Cry1\u2212\/\u2212) exhibit resistance to obesity induced by a high-fat diet. Front Endocrinol (Lausanne) 5:49. https:\/\/doi.org\/10.3389\/FENDO.2014.00049","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10194_CR22","doi-asserted-by":"publisher","first-page":"1736978","DOI":"10.3389\/FNINS.2026.1736978\/FULL","volume":"20","author":"CM Dr\u0103goi","year":"2026","unstructured":"Dr\u0103goi CM, Dumitrescu IB, Nicolae AC (2026) Rhythms of life: melatonin, nutrition, sleep, and antioxidant strategies for healthy aging. Front Neurosci 20:1736978. https:\/\/doi.org\/10.3389\/FNINS.2026.1736978\/FULL","journal-title":"Front Neurosci"},{"key":"10194_CR23","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/J.PSYNEUEN.2015.08.021","volume":"62","author":"JJ Joseph","year":"2015","unstructured":"Joseph JJ, Wang X, Spanakis E, Seeman T, Wand G, Needham B et al (2015) Diurnal salivary cortisol, glycemia and insulin resistance: the multi-ethnic study of atherosclerosis. Psychoneuroendocrinology 62:327. https:\/\/doi.org\/10.1016\/J.PSYNEUEN.2015.08.021","journal-title":"Psychoneuroendocrinology"},{"key":"10194_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/FENDO.2021.585887","volume":"12","author":"M Obradovic","year":"2021","unstructured":"Obradovic M, Sudar-Milovanovic E, Soskic S, Essack M, Arya S, Stewart AJ et al (2021) Leptin and obesity: role and clinical implication. Front Endocrinol (Lausanne) 12:585887. https:\/\/doi.org\/10.3389\/FENDO.2021.585887","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10194_CR25","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/S41574-023-00927-Z","volume":"20","author":"SS Kulkarni","year":"2023","unstructured":"Kulkarni SS, Singh O, Zigman JM (2023) The intersection between ghrelin, metabolism and circadian rhythms. Nat Rev Endocrinol 20:228. https:\/\/doi.org\/10.1038\/S41574-023-00927-Z","journal-title":"Nat Rev Endocrinol"},{"key":"10194_CR26","unstructured":"Vargas E, Carrillo Sepulveda MA (2026) Biochemistry, insulin metabolic eff ects. StatPearls, pp 1\u201325"},{"key":"10194_CR27","doi-asserted-by":"publisher","DOI":"10.1177\/20420188231222371","volume":"15","author":"MMI Abdalla","year":"2024","unstructured":"Abdalla MMI (2024) Therapeutic potential of adiponectin in prediabetes: strategies, challenges, and future directions. Ther Adv Endocrinol Metab 15:20420188231222372. https:\/\/doi.org\/10.1177\/20420188231222371","journal-title":"Ther Adv Endocrinol Metab"},{"key":"10194_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/J.BJ.2025.100827","volume":"48","author":"MT Crespo","year":"2025","unstructured":"Crespo MT, Trebucq LL, Senna CA, Hokama G, Paladino N, Agostino PV et al (2025) Circadian disruption of feeding-fasting rhythm and its consequences for metabolic, immune, cancer, and cognitive processes. Biomed J 48:100827. https:\/\/doi.org\/10.1016\/J.BJ.2025.100827","journal-title":"Biomed J"},{"key":"10194_CR29","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1186\/S13098-025-01871-W","volume":"17","author":"Y Jiao","year":"2025","unstructured":"Jiao Y, Butoyi C, Zhang Q, Intchasso Adotey SAA, Chen M, Shen W et al (2025) Sleep disorders impact hormonal regulation: unravelling the relationship among sleep disorders, hormones and metabolic diseases. Diabetol Metab Syndr 17:305. https:\/\/doi.org\/10.1186\/S13098-025-01871-W","journal-title":"Diabetol Metab Syndr"},{"issue":"1","key":"10194_CR30","doi-asserted-by":"publisher","first-page":"e1017","DOI":"10.1038\/tp.2016.262","volume":"7","author":"TA Bedrosian","year":"2017","unstructured":"Bedrosian TA, Nelson RJ (2017) Timing of light exposure affects mood and brain circuits. Transl Psychiatry 7(1):e1017. https:\/\/doi.org\/10.1038\/tp.2016.262","journal-title":"Transl Psychiatry"},{"key":"10194_CR31","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/S42003-025-07932-0","volume":"8","author":"AL Hunter","year":"2025","unstructured":"Hunter AL, Bechtold DA (2025) The metabolic significance of peripheral tissue clocks. Commun Biol 8:497. https:\/\/doi.org\/10.1038\/S42003-025-07932-0","journal-title":"Commun Biol"},{"key":"10194_CR32","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/S13311-021-01031-8","volume":"18","author":"TA Steele","year":"2021","unstructured":"Steele TA, St Louis EK, Videnovic A, Auger RR (2021) Circadian rhythm sleep\u2013wake disorders: a contemporary review of neurobiology, treatment, and dysregulation in neurodegenerative disease. Neurotherapeutics 18:53\u201374. https:\/\/doi.org\/10.1007\/S13311-021-01031-8","journal-title":"Neurotherapeutics"},{"key":"10194_CR33","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/S41574-022-00747-7","volume":"19","author":"JP Chaput","year":"2022","unstructured":"Chaput JP, McHill AW, Cox RC, Broussard JL, Dutil C, da Costa BGG et al (2022) The role of insufficient sleep and circadian misalignment in obesity. Nat Rev Endocrinol 19:82. https:\/\/doi.org\/10.1038\/S41574-022-00747-7","journal-title":"Nat Rev Endocrinol"},{"key":"10194_CR34","doi-asserted-by":"publisher","unstructured":"Duez H, Staels B (2025) Circadian disruption and the risk of developing obesity. Curr Obes Rep 14. https:\/\/doi.org\/10.1007\/S13679-025-00610-6","DOI":"10.1007\/S13679-025-00610-6"},{"key":"10194_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/J.BJ.2025.100872","volume":"49","author":"S Chen","year":"2025","unstructured":"Chen S, Ciccone N, Ray D (2025) The clockwork macrophage: timing in innate immunity. Biomed J 49:100872. https:\/\/doi.org\/10.1016\/J.BJ.2025.100872","journal-title":"Biomed J"},{"key":"10194_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/S12967-025-06250-7","volume":"23","author":"L Zinna","year":"2025","unstructured":"Zinna L, Verde L, Tolla MFD, Barrea L, Parascandolo A, D\u2019Alterio F et al (2025) Chronodisruption enhances inflammatory cytokine release from visceral adipose tissue in obesity. J Transl Med 23:231. https:\/\/doi.org\/10.1186\/S12967-025-06250-7","journal-title":"J Transl Med"},{"key":"10194_CR37","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20212358","author":"Y Qi","year":"2022","unstructured":"Qi Y, Hui X (2022) The shades of grey in adipose tissue reprogramming. Biosci Rep. https:\/\/doi.org\/10.1042\/BSR20212358","journal-title":"Biosci Rep"},{"key":"10194_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/MCO2.504","volume":"5","author":"Y Lin","year":"2024","unstructured":"Lin Y, He L, Cai Y, Wang X, Wang S, Li F (2024) The role of circadian clock in regulating cell functions: implications for diseases. MedComm (Beijing) 5:e504. https:\/\/doi.org\/10.1002\/MCO2.504","journal-title":"MedComm (Beijing)"},{"key":"10194_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/J.EJPHAR.2026.178602","volume":"1016","author":"EA Elmorsy","year":"2026","unstructured":"Elmorsy EA, Hatem MM, Alsaykhan H, Alsalloom AA, Khodeir MM, Alorini M et al (2026) Reprogramming lysosomal\u2013purinergic crosstalk governs the synergistic attenuation of NLRP3 inflammasome activation by cyclodextrin\u2013P2X7 blockade in diabetic rats. Eur J Pharmacol 1016:178602. https:\/\/doi.org\/10.1016\/J.EJPHAR.2026.178602","journal-title":"Eur J Pharmacol"},{"key":"10194_CR40","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/S41584-022-00784-6","volume":"18","author":"N Burg","year":"2022","unstructured":"Burg N, Salmon JE, Hla T (2022) Sphingosine 1-phosphate receptor-targeted therapeutics in rheumatic diseases. Nat Rev Rheumatol 18:335. https:\/\/doi.org\/10.1038\/S41584-022-00784-6","journal-title":"Nat Rev Rheumatol"},{"key":"10194_CR41","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/J.TCB.2011.09.003","volume":"22","author":"M Maceyka","year":"2012","unstructured":"Maceyka M, Harikumar KB, Milstien S, Spiegel S (2012) Sphingosine-1-phosphate signaling and its role in disease. Trends Cell Biol 22:50\u201360. https:\/\/doi.org\/10.1016\/J.TCB.2011.09.003","journal-title":"Trends Cell Biol"},{"key":"10194_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/J.BCP.2024.116158","volume":"223","author":"B \u0141ukaszuk","year":"2024","unstructured":"\u0141ukaszuk B, Supruniuk E, Chabowski A, Mik\u0142osz A (2024) Adipose tissue place of origin and obesity influence sphingolipid signaling pathway in the adipocytes differentiated from ADMSCs isolated from morbidly obese women. Biochem Pharmacol 223:116158. https:\/\/doi.org\/10.1016\/J.BCP.2024.116158","journal-title":"Biochem Pharmacol"},{"key":"10194_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2019.01409\/FULL","volume":"10","author":"L Xiao","year":"2019","unstructured":"Xiao L, Zhou Y, Friis T, Beagley K, Xiao Y (2019) S1p\u2013S1PR1 signaling: the \u201cSphinx\u201d in osteoimmunology. Front Immunol 10:441051. https:\/\/doi.org\/10.3389\/FIMMU.2019.01409\/FULL","journal-title":"Front Immunol"},{"key":"10194_CR44","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/J.CMET.2021.06.006","volume":"33","author":"CD Green","year":"2021","unstructured":"Green CD, Maceyka M, Cowart LA, Spiegel S (2021) Sphingolipids in metabolic disease: the good, the bad, and the unknown. Cell Metab 33:1293. https:\/\/doi.org\/10.1016\/J.CMET.2021.06.006","journal-title":"Cell Metab"},{"key":"10194_CR45","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/978-3-319-05879-5_4","volume":"378","author":"Y Xiong","year":"2014","unstructured":"Xiong Y, Hla T (2014) S1P control of endothelial integrity. Curr Top Microbiol Immunol 378:85. https:\/\/doi.org\/10.1007\/978-3-319-05879-5_4","journal-title":"Curr Top Microbiol Immunol"},{"key":"10194_CR46","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1080\/21623945.2021.2021700","volume":"11","author":"S Chakrabarty","year":"2022","unstructured":"Chakrabarty S, Bui Q, Badeanlou L, Hester K, Chun J, Ruf W et al (2022) S1P\/S1PR3 signalling axis protects against obesity-induced metabolic dysfunction. Adipocyte 11:69. https:\/\/doi.org\/10.1080\/21623945.2021.2021700","journal-title":"Adipocyte"},{"key":"10194_CR47","doi-asserted-by":"publisher","first-page":"10265","DOI":"10.3390\/IJMS262110265\/S1","volume":"26","author":"JSY Cheah","year":"2025","unstructured":"Cheah JSY, Skarratt KK, Fuller SJ, Balle T (2025) Genetic variations in the P2X7 receptor: opportunities and challenges for drug development. Int J Mol Sci 26:10265. https:\/\/doi.org\/10.3390\/IJMS262110265\/S1","journal-title":"Int J Mol Sci"},{"key":"10194_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/FPHAR.2021.654425","volume":"12","author":"J Zhou","year":"2021","unstructured":"Zhou J, Zhou Z, Liu X, Yin HY, Tang Y, Cao X (2021) P2X7 receptor\u2013mediated inflammation in cardiovascular disease. Front Pharmacol 12:654425. https:\/\/doi.org\/10.3389\/FPHAR.2021.654425","journal-title":"Front Pharmacol"},{"key":"10194_CR49","doi-asserted-by":"publisher","unstructured":"Patel A, Jain P, Ajazuddin (2025) Recent advances in the therapeutics and modes of action of a range of agents used to treat ulcerative colitis and related inflammatory conditions. Inflammopharmacol. https:\/\/doi.org\/10.1007\/s10787-025-01906-8","DOI":"10.1007\/s10787-025-01906-8"},{"key":"10194_CR50","doi-asserted-by":"publisher","first-page":"C375","DOI":"10.1152\/AJPCELL.00379.2020","volume":"320","author":"T Kawai","year":"2020","unstructured":"Kawai T, Autieri MV, Scalia R (2020) Adipose tissue inflammation and metabolic dysfunction in obesity. Am J Physiol Cell Physiol 320:C375. https:\/\/doi.org\/10.1152\/AJPCELL.00379.2020","journal-title":"Am J Physiol Cell Physiol"},{"key":"10194_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/S12915-020-00918-W","volume":"18","author":"W Wang","year":"2020","unstructured":"Wang W, Hu D, Feng Y, Wu C, Song Y, Liu W et al (2020) Paxillin mediates ATP-induced activation of P2X7 receptor and NLRP3 inflammasome. BMC Biol 18:182. https:\/\/doi.org\/10.1186\/S12915-020-00918-W","journal-title":"BMC Biol"},{"key":"10194_CR52","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/S11357-019-00151-6","volume":"42","author":"D Ca\u00f1adas-Lozano","year":"2020","unstructured":"Ca\u00f1adas-Lozano D, Mar\u00edn-Aguilar F, Castej\u00f3n-Vega B, Ryffel B, Navarro-Pando JM, Ruiz-Cabello J et al (2020) Blockade of the NLRP3 inflammasome improves metabolic health and lifespan in obese mice. Geroscience 42:715. https:\/\/doi.org\/10.1007\/S11357-019-00151-6","journal-title":"Geroscience"},{"key":"10194_CR53","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.immuni.2017.06.020","volume":"47","author":"F Di Virgilio","year":"2017","unstructured":"Di Virgilio F, Dal Ben D, Sarti AC, Giuliani AL, Falzoni S (2017) The P2X7 receptor in infection and inflammation. Immunity 47:15\u201331. https:\/\/doi.org\/10.1016\/j.immuni.2017.06.020","journal-title":"Immunity"},{"key":"10194_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/FPHYS.2019.01607","volume":"10","author":"F Zatterale","year":"2020","unstructured":"Zatterale F, Longo M, Naderi J, Raciti GA, Desiderio A, Miele C et al (2020) Chronic adipose tissue inflammation linking obesity to insulin resistance and type 2 diabetes. Front Physiol 10:1607. https:\/\/doi.org\/10.3389\/FPHYS.2019.01607","journal-title":"Front Physiol"},{"key":"10194_CR55","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/978-3-030-21735-8_15","volume":"1161","author":"S Albeituni","year":"2019","unstructured":"Albeituni S, Stiban J (2019) Roles of ceramides and other sphingolipids in immune cell function and inflammation. Adv Exp Med Biol 1161:169\u2013191. https:\/\/doi.org\/10.1007\/978-3-030-21735-8_15","journal-title":"Adv Exp Med Biol"},{"key":"10194_CR56","doi-asserted-by":"publisher","unstructured":"Shi W, Tan H, Liao C, An Z (2025) Cross-regulation between adipose tissue innervation and metaflammation: a potential therapeutic target for obesity. Am J Transl Res 17:4087. https:\/\/doi.org\/10.62347\/AIWS5429","DOI":"10.62347\/AIWS5429"},{"key":"10194_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/FENDO.2021.635995","volume":"12","author":"I Juchnicka","year":"2021","unstructured":"Juchnicka I, Ku\u017amicki M, Szamatowicz J (2021) Ceramides and sphingosino-1-phosphate in obesity. Front Endocrinol (Lausanne) 12:635995. https:\/\/doi.org\/10.3389\/FENDO.2021.635995","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10194_CR58","doi-asserted-by":"publisher","unstructured":"Di Vincenzo A, Granzotto M, Crescenzi M, Capone F, Fioretto P, Rossato M (2026) Novel insights into the purinergic P2X7 receptor signaling in obesity and cardiovascular-kidney-metabolic syndrome: a brief overview. Metabolism and Target Organ Damage 6. https:\/\/doi.org\/10.20517\/MTOD.2025.105","DOI":"10.20517\/MTOD.2025.105"},{"key":"10194_CR59","doi-asserted-by":"publisher","first-page":"1174789","DOI":"10.3389\/FIMMU.2023.1174789\/TEXT","volume":"14","author":"Y Liu","year":"2023","unstructured":"Liu Y, Zheng P (2023) CD24-Siglec interactions in inflammatory diseases. Front Immunol 14:1174789. https:\/\/doi.org\/10.3389\/FIMMU.2023.1174789\/TEXT","journal-title":"Front Immunol"},{"key":"10194_CR60","doi-asserted-by":"publisher","first-page":"3475","DOI":"10.3390\/JCM14103475","volume":"14","author":"XY Choon","year":"2025","unstructured":"Choon XY, Yeo JH, White C, Sharma E, Samaan MA (2025) The current sphingosine 1 phosphate receptor modulators in the management of ulcerative colitis. J Clin Med 14:3475. https:\/\/doi.org\/10.3390\/JCM14103475","journal-title":"J Clin Med"},{"issue":"1","key":"10194_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-05233-4","volume":"15","author":"M Zarkesh","year":"2025","unstructured":"Zarkesh M, Saba R, Aghazadeh H, Teymoori F, Akbarzadeh M, Asghari G et al (2025) The association of PTEN\/PI3K\/Akt pathway gene expression with insulin indices in adipose tissues of non-diabetic female adults: a cross-sectional study. Sci Rep 15(1):20592-. https:\/\/doi.org\/10.1038\/s41598-025-05233-4","journal-title":"Sci Rep"},{"key":"10194_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/J.BIOPHA.2021.112170","volume":"143","author":"HJ Zhang","year":"2021","unstructured":"Zhang HJ, Liao HY, Bai DY, Wang ZQ, Xie XW (2021) MAPK \/ERK signaling pathway: a potential target for the treatment of intervertebral disc degeneration. Biomed Pharmacother 143:112170. https:\/\/doi.org\/10.1016\/J.BIOPHA.2021.112170","journal-title":"Biomed Pharmacother"},{"key":"10194_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/SIGTRANS.2017.23","volume":"2","author":"T Liu","year":"2017","unstructured":"Liu T, Zhang L, Joo D, Sun SC (2017) NF-\u03baB signaling in inflammation. Signal Transduct Target Ther 2:17023. https:\/\/doi.org\/10.1038\/SIGTRANS.2017.23","journal-title":"Signal Transduct Target Ther"},{"key":"10194_CR64","doi-asserted-by":"publisher","DOI":"10.1002\/MCO2.70660","volume":"7","author":"C Zou","year":"2026","unstructured":"Zou C, Jiang S, Li H, Zhao K, Cao D, Yang G (2026) The NLRP3 inflammasome: mechanisms of activation, regulation, and therapeutic opportunities. MedComm (Beijing) 7:e70660. https:\/\/doi.org\/10.1002\/MCO2.70660","journal-title":"MedComm (Beijing)"},{"key":"10194_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/J.CYTOGFR.2016.05.001","volume":"31","author":"EJ Hillmer","year":"2016","unstructured":"Hillmer EJ, Zhang H, Li HS, Watowich SS (2016) STAT3 signaling in immunity. Cytokine Growth Factor Rev 31:1. https:\/\/doi.org\/10.1016\/J.CYTOGFR.2016.05.001","journal-title":"Cytokine Growth Factor Rev"},{"key":"10194_CR66","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS20010187","volume":"20","author":"A Daiber","year":"2019","unstructured":"Daiber A, Xia N, Steven S, Oelze M, Hanf A, Kr\u00f6ller-Sch\u00f6n S et al (2019) New therapeutic implications of endothelial nitric oxide synthase (eNOS) function\/dysfunction in cardiovascular disease. Int J Mol Sci 20:187. https:\/\/doi.org\/10.3390\/IJMS20010187","journal-title":"Int J Mol Sci"},{"key":"10194_CR67","doi-asserted-by":"publisher","first-page":"R453","DOI":"10.1016\/J.CUB.2014.03.034","volume":"24","author":"M Schieber","year":"2014","unstructured":"Schieber M, Chandel NS (2014) ROS function in redox signaling and oxidative stress. Curr Biol 24:R453. https:\/\/doi.org\/10.1016\/J.CUB.2014.03.034","journal-title":"Curr Biol"},{"key":"10194_CR68","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2026.2620329","volume":"58","author":"L Li","year":"2026","unstructured":"Li L, Yao M, Meng J, Zhong Z, Nan N, Kazemi AH et al (2026) Advances in calcium signalling research for the diagnosis and treatment of depression. Ann Med 58:2620329. https:\/\/doi.org\/10.1080\/07853890.2026.2620329","journal-title":"Ann Med"},{"key":"10194_CR69","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/J.IMMUNI.2013.05.016","volume":"38","author":"R Mu\u00f1oz-Planillo","year":"2013","unstructured":"Mu\u00f1oz-Planillo R, Kuffa P, Mart\u00ednez-Col\u00f3n G, Smith BL, Rajendiran TM, N\u00fa\u00f1ez G (2013) K+ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. Immunity 38:1142. https:\/\/doi.org\/10.1016\/J.IMMUNI.2013.05.016","journal-title":"Immunity"},{"key":"10194_CR70","doi-asserted-by":"publisher","DOI":"10.3390\/PHARMACEUTICS14122657","volume":"14","author":"T Khan","year":"2022","unstructured":"Khan T, Waseem R, Zehra Z, Aiman A, Bhardwaj P, Ansari J et al (2022) Mitochondrial dysfunction: pathophysiology and mitochondria-targeted drug delivery approaches. Pharmaceutics 14:2657. https:\/\/doi.org\/10.3390\/PHARMACEUTICS14122657","journal-title":"Pharmaceutics"},{"key":"10194_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/J.IT.2026.03.001","author":"S van Kesteren","year":"2026","unstructured":"van Kesteren S, Smeehuijzen L, Stevenson R, Kroon J (2026) Endothelial cells modulate immune cell responses during atherosclerosis. Trends Immunol. https:\/\/doi.org\/10.1016\/J.IT.2026.03.001","journal-title":"Trends Immunol"},{"issue":"1","key":"10194_CR72","doi-asserted-by":"publisher","DOI":"10.1007\/S00018-025-06041-9","volume":"83","author":"W He","year":"2026","unstructured":"He W, Xu J, Li X (2026) Macrophage polarization in inflammatory regulation: molecular mechanisms, therapeutic targets, and translational challenges. Cell Mol Life Sci 83(1):164. https:\/\/doi.org\/10.1007\/S00018-025-06041-9","journal-title":"Cell Mol Life Sci"},{"key":"10194_CR73","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2024.1352946","volume":"15","author":"M Luo","year":"2024","unstructured":"Luo M, Zhao F, Cheng H, Su M, Wang Y (2024) Macrophage polarization: an important role in inflammatory diseases. Front Immunol 15:1352946. https:\/\/doi.org\/10.3389\/FIMMU.2024.1352946","journal-title":"Front Immunol"},{"key":"10194_CR74","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1089\/JIR.2008.0027","volume":"29","author":"SL Deshmane","year":"2009","unstructured":"Deshmane SL, Kremlev S, Amini S, Sawaya BE (2009) Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res 29:313. https:\/\/doi.org\/10.1089\/JIR.2008.0027","journal-title":"J Interferon Cytokine Res"},{"key":"10194_CR75","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/J.EJPHAR.2016.02.056","volume":"776","author":"W Liu","year":"2016","unstructured":"Liu W, Liu B, Liu S, Zhang J, Lin S (2016) Sphingosine-1-phosphate receptor 2 mediates endothelial cells dysfunction by PI3K-Akt pathway under high glucose condition. Eur J Pharmacol 776:19\u201325. https:\/\/doi.org\/10.1016\/J.EJPHAR.2016.02.056","journal-title":"Eur J Pharmacol"},{"key":"10194_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/J.JPHA.2023.12.003","volume":"14","author":"Y Han","year":"2024","unstructured":"Han Y, Sun Q, Chen W, Gao Y, Ye J, Chen Y et al (2024) New advances of adiponectin in regulating obesity and related metabolic syndromes. J Pharm Anal 14:100913. https:\/\/doi.org\/10.1016\/J.JPHA.2023.12.003","journal-title":"J Pharm Anal"},{"key":"10194_CR77","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0204229","volume":"13","author":"E Nuka","year":"2018","unstructured":"Nuka E, Ohnishi K, Terao J, Kawai Y (2018) ATP\/P2X7 receptor signaling as a potential anti-inflammatory target of natural polyphenols. PLoS One 13:e0204229. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0204229","journal-title":"PLoS One"},{"key":"10194_CR78","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/J.CMET.2012.06.017","volume":"16","author":"T Hla","year":"2012","unstructured":"Hla T, Dannenberg AJ (2012) Sphingolipid signaling in metabolic disorders. Cell Metab 16:420\u201334. https:\/\/doi.org\/10.1016\/J.CMET.2012.06.017","journal-title":"Cell Metab"},{"key":"10194_CR79","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS27031237","volume":"27","author":"E Gusev","year":"2026","unstructured":"Gusev E, Sarapultsev A, Zhuravleva Y (2026) Insulin resistance and inflammation. Int J Mol Sci 27:1237. https:\/\/doi.org\/10.3390\/IJMS27031237","journal-title":"Int J Mol Sci"},{"key":"10194_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijnurstu.2025.105112","author":"HA Br\u00fcckner","year":"2025","unstructured":"Br\u00fcckner HA, Ell J, Kalon L, Strahler J, Ducki A, Riemann D et al (2025) Effectiveness of digital cognitive behavioral therapy for insomnia in nurses with shift work sleep disorder: results of a randomized controlled trial. Int J Nurs Stud. https:\/\/doi.org\/10.1016\/j.ijnurstu.2025.105112","journal-title":"Int J Nurs Stud"},{"key":"10194_CR81","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1053\/j.gastro.2017.12.019","volume":"154","author":"B Pourcet","year":"2018","unstructured":"Pourcet B, Zecchin M, Ferri L, Beauchamp J, Sitaula S, Billon C et al (2018) Nuclear receptor subfamily 1 group D member 1 regulates circadian activity of NLRP3 inflammasome to reduce the severity of fulminant hepatitis in mice. Gastroenterology 154:1449-1464.e20. https:\/\/doi.org\/10.1053\/j.gastro.2017.12.019","journal-title":"Gastroenterology"},{"key":"10194_CR82","doi-asserted-by":"publisher","DOI":"10.1096\/FJ.202400508RR;PAGE:STRING:ARTICLE\/CHAPTER","volume":"38","author":"JR O\u2019Siorain","year":"2024","unstructured":"O\u2019Siorain JR, Cox SL, Payet C, Nally FK, He Y, Drewinksi TT et al (2024) Time-of-day control of mitochondria regulates NLRP3 inflammasome activation in macrophages. FASEB J 38:e70235. https:\/\/doi.org\/10.1096\/FJ.202400508RR;PAGE:STRING:ARTICLE\/CHAPTER","journal-title":"FASEB J"},{"key":"10194_CR83","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/S41398-020-01189-3","volume":"11","author":"C Smith","year":"2021","unstructured":"Smith C, Trageser KJ, Wu H, Herman FJ, Iqbal UH, Sebastian-Valverde M et al (2021) Anxiolytic effects of NLRP3 inflammasome inhibition in a model of chronic sleep deprivation. Transl Psychiatry 11:52. https:\/\/doi.org\/10.1038\/S41398-020-01189-3","journal-title":"Transl Psychiatry"},{"key":"10194_CR84","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3390\/BIOM10020291","volume":"10","author":"IK Kwaifa","year":"2020","unstructured":"Kwaifa IK, Bahari H, Yong YK, Md NS (2020) Endothelial dysfunction in obesity-induced inflammation: molecular mechanisms and clinical implications. Biomolecules 10:291. https:\/\/doi.org\/10.3390\/BIOM10020291","journal-title":"Biomolecules"},{"key":"10194_CR85","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/J.BIOACTMAT.2024.12.013","volume":"46","author":"L Wang","year":"2024","unstructured":"Wang L, Yu C, You T, Zhang X, Su H, Cao B et al (2024) Injection of ROS-responsive hydrogel loaded with IL-1\u03b2-targeted nanobody for ameliorating myocardial infarction. Bioact Mater 46:273. https:\/\/doi.org\/10.1016\/J.BIOACTMAT.2024.12.013","journal-title":"Bioact Mater"},{"key":"10194_CR86","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/508409","author":"L Chen","year":"2015","unstructured":"Chen L, Chen R, Wang H, Liang F (2015) Mechanisms linking inflammation to insulin resistance. Int J Endocrinol. https:\/\/doi.org\/10.1155\/2015\/508409","journal-title":"Int J Endocrinol"},{"key":"10194_CR87","doi-asserted-by":"publisher","unstructured":"Patel A, Jain P, Thakur A, Ajazuddin (2025) Recent review on herbs and medicinal plant-based nanotechnological approach in treating psoriasis. Curr Bioact Compd 21. https:\/\/doi.org\/10.2174\/0115734072312903240523060831","DOI":"10.2174\/0115734072312903240523060831"},{"key":"10194_CR88","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2026.1856864","author":"Z Wang","year":"2026","unstructured":"Wang Z, Li B, Shen X, Shen B, Yang C, Huang L et al (2026) Protective effect and mechanisms of Buyang Huanwu decoction against hypobaric hypoxia-induced brain injury in mice: involvement of inflammatory responses and HIF-1\/PI3K-Akt-related pathways. Front Immunol. https:\/\/doi.org\/10.3389\/FIMMU.2026.1856864","journal-title":"Front Immunol"},{"key":"10194_CR89","unstructured":"Collins L, Costello RA (2024) Glucagon-like peptide-1 receptor agonists. StatPearls, pp 1\u201326"},{"key":"10194_CR90","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS25179351","volume":"25","author":"C Delrue","year":"2024","unstructured":"Delrue C, Speeckaert MM (2024) Mechanistic pathways and clinical implications of GLP-1 receptor agonists in type 1 diabetes management. Int J Mol Sci 25:9351. https:\/\/doi.org\/10.3390\/IJMS25179351","journal-title":"Int J Mol Sci"},{"key":"10194_CR91","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1016\/S0140-6736(25)02165-8","volume":"406","author":"DB Horn","year":"2026","unstructured":"Horn DB, Ryan DH, Kis SG, Alves B, Mu Y, Kim SG et al (2026) Orforglipron, an oral small-molecule GLP-1 receptor agonist, for the treatment of obesity in people with type 2 diabetes (ATTAIN-2): a phase 3, double-blind, randomised, multicentre, placebo-controlled trial. Lancet 406:2927\u20132944. https:\/\/doi.org\/10.1016\/S0140-6736(25)02165-8","journal-title":"Lancet"},{"key":"10194_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2025.106819","author":"P Bielawiec","year":"2025","unstructured":"Bielawiec P, Swierkot L, Konstantynowicz-Nowicka K, Chabowski A, B\u0142achnio-Zabielska A, Harasim-Symbor E (2025) Cannabigerol \u2013 a potent regulator of insulin sensitivity in rat\u2019s skeletal muscle via targeting the sphingolipid metabolism and PI3K\/Akt\/mTOR pathway? Int J Biochem Cell Biol. https:\/\/doi.org\/10.1016\/j.biocel.2025.106819","journal-title":"Int J Biochem Cell Biol"},{"key":"10194_CR93","doi-asserted-by":"publisher","DOI":"10.3390\/CELLS12141844","author":"S Alam","year":"2023","unstructured":"Alam S, Afsar SY, Wolter MA, Volk LM, Mitroi DN, Meyer zu Heringdorf D et al (2023) S1P lyase deficiency in the brain promotes astrogliosis and NLRP3 inflammasome activation via purinergic signaling. Cells. https:\/\/doi.org\/10.3390\/CELLS12141844","journal-title":"Cells"},{"key":"10194_CR94","doi-asserted-by":"publisher","first-page":"922","DOI":"10.17305\/BB.2023.9082","volume":"23","author":"J Li","year":"2023","unstructured":"Li J, Huang Y, Zhang Y, Liu P, Liu M, Zhang M et al (2023) S1P\/S1PR signaling pathway advancements in autoimmune diseases. Biomolecules Biomed 23:922. https:\/\/doi.org\/10.17305\/BB.2023.9082","journal-title":"Biomolecules Biomed"},{"key":"10194_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/J.YEXMP.2026.105041","volume":"146","author":"K Atchou","year":"2026","unstructured":"Atchou K, Madalageri M, Manandhar S, Pai KSR (2026) Targeting P2X7 receptor\/NLRP1 inflammasome axis and gut dysbiosis: a mechanistic review of pyroptosis in metabolic inflammation. Exp Mol Pathol 146:105041. https:\/\/doi.org\/10.1016\/J.YEXMP.2026.105041","journal-title":"Exp Mol Pathol"},{"key":"10194_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/J.PHRS.2022.106320","volume":"182","author":"G Bendotti","year":"2022","unstructured":"Bendotti G, Montefusco L, Lunati ME, Usuelli V, Pastore I, Lazzaroni E et al (2022) The anti-inflammatory and immunological properties of GLP-1 receptor agonists. Pharmacol Res 182:106320. https:\/\/doi.org\/10.1016\/J.PHRS.2022.106320","journal-title":"Pharmacol Res"},{"key":"10194_CR97","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/J.MOLIMM.2013.11.015","volume":"59","author":"K Schaper","year":"2014","unstructured":"Schaper K, Kietzmann M, B\u00e4umer W (2014) Sphingosine-1-phosphate differently regulates the cytokine production of IL-12, IL-23 and IL-27 in activated murine bone marrow derived dendritic cells. Mol Immunol 59:10\u20138. https:\/\/doi.org\/10.1016\/J.MOLIMM.2013.11.015","journal-title":"Mol Immunol"},{"key":"10194_CR98","doi-asserted-by":"publisher","DOI":"10.1186\/S12915-020-00918-W","author":"W Wang","year":"2020","unstructured":"Wang W, Hu D, Feng Y, Wu C, Song Y, Liu W et al (2020) Paxillin mediates ATP-induced activation of P2X7 receptor and NLRP3 inflammasome. BMC Biol. https:\/\/doi.org\/10.1186\/S12915-020-00918-W","journal-title":"BMC Biol"},{"key":"10194_CR99","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1021\/ACSCHEMNEURO.2C00133","volume":"13","author":"ADJ McKenzie","year":"2022","unstructured":"McKenzie ADJ, Garrett TR, Werry EL, Kassiou M (2022) Purinergic P2X7 receptor: a therapeutic target in amyotrophic lateral sclerosis. ACS Chem Neurosci 13:1479\u20131490. https:\/\/doi.org\/10.1021\/ACSCHEMNEURO.2C00133","journal-title":"ACS Chem Neurosci"},{"key":"10194_CR100","doi-asserted-by":"publisher","DOI":"10.3390\/METABO16030207","volume":"16","author":"A Qadeer","year":"2026","unstructured":"Qadeer A, Ullah A, Khan MZ, Alsharif KF, Alzahrani FM, Alzahrani KJ et al (2026) Extracellular vesicles associated metabolites as intercellular signalling mediators in disease and therapy. Metabolites 16:207. https:\/\/doi.org\/10.3390\/METABO16030207","journal-title":"Metabolites"},{"key":"10194_CR101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5455\/NJPPP.2024.14.08352202422082024","volume":"14","author":"A Shah","year":"2024","unstructured":"Shah A, Shah S (2024) Chronopharmacology: optimizing drug therapy through biological rhythms. Natl J Physiol Pharm Pharmacol 14:1. https:\/\/doi.org\/10.5455\/NJPPP.2024.14.08352202422082024","journal-title":"Natl J Physiol Pharm Pharmacol"},{"key":"10194_CR102","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0252353","author":"SP Bhatt","year":"2021","unstructured":"Bhatt SP, Guleria R, Kabra SK (2021) Metabolic alterations and systemic inflammation in overweight\/obese children with obstructive sleep apnea. PLoS ONE. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0252353","journal-title":"PLoS ONE"},{"key":"10194_CR103","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/JNT6030021","volume":"6","author":"M Moghimi","year":"2025","unstructured":"Moghimi M, Alanazi A, Craven A, Spirou SV, Santos-Martinez MJ, Medina C et al (2025) Nanomedicine as a promising treatment approach for obesity. J Nanotheranostics 6:21. https:\/\/doi.org\/10.3390\/JNT6030021","journal-title":"J Nanotheranostics"},{"key":"10194_CR104","doi-asserted-by":"publisher","DOI":"10.1002\/ADVS.202501813","volume":"12","author":"W Chang","year":"2025","unstructured":"Chang W, Meng Z, Zhao Y, Qi Y, Li Z, Lian H (2025) Emerging nanotechnology strategies for obesity therapy. Adv Sci 12:e01813. https:\/\/doi.org\/10.1002\/ADVS.202501813","journal-title":"Adv Sci"},{"key":"10194_CR105","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1111\/J.1476-5381.2009.00451.X","volume":"158","author":"V Brinkmann","year":"2009","unstructured":"Brinkmann V (2009) FTY720 (fingolimod) in multiple sclerosis: therapeutic effects in the immune and the central nervous system. Br J Pharmacol 158:1173. https:\/\/doi.org\/10.1111\/J.1476-5381.2009.00451.X","journal-title":"Br J Pharmacol"},{"key":"10194_CR106","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS27125200","volume":"27","author":"K Czubowicz","year":"2026","unstructured":"Czubowicz K, Motyl JA, Wencel A, Strosznajder RP (2026) The role of sphingosine-1-phosphate signaling in cerebral ischemia\/reperfusion injury and Alzheimer\u2019s disease pathology. Int J Mol Sci 27:5200. https:\/\/doi.org\/10.3390\/IJMS27125200","journal-title":"Int J Mol Sci"},{"key":"10194_CR107","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0193236","volume":"13","author":"KRT Meadows","year":"2018","unstructured":"Meadows KRT, Steinberg MW, Clemons B, Stokes ME, Opiteck GJ, Peach R et al (2018) Ozanimod (RPC1063), a selective S1PR1 and S1PR5 modulator, reduces chronic inflammation and alleviates kidney pathology in murine systemic lupus erythematosus. PLoS ONE 13:e0193236. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0193236","journal-title":"PLoS ONE"},{"key":"10194_CR108","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1177\/2040622315617354","volume":"7","author":"D D\u2019ambrosio","year":"2016","unstructured":"D\u2019ambrosio D, Freedman MS, Prinz J (2016) Ponesimod, a selective S1P1 receptor modulator: a potential treatment for multiple sclerosis and other immune-mediated diseases. Ther Adv Chronic Dis 7:18. https:\/\/doi.org\/10.1177\/2040622315617354","journal-title":"Ther Adv Chronic Dis"},{"key":"10194_CR109","doi-asserted-by":"publisher","first-page":"3890","DOI":"10.3390\/JCM14113890","volume":"14","author":"C Martinez-Molina","year":"2025","unstructured":"Martinez-Molina C, Gonz\u00e1lez-Su\u00e1rez B (2025) Etrasimod: modulating sphingosine-1-phosphate receptors to treat ulcerative colitis. J Clin Med 14:3890. https:\/\/doi.org\/10.3390\/JCM14113890","journal-title":"J Clin Med"},{"key":"10194_CR110","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/BPH.13641","volume":"174","author":"K Sugahara","year":"2017","unstructured":"Sugahara K, Maeda Y, Shimano K, Mogami A, Kataoka H, Ogawa K et al (2017) Amiselimod, a novel sphingosine 1-phosphate receptor-1 modulator, has potent therapeutic efficacy for autoimmune diseases, with low bradycardia risk. Br J Pharmacol 174:15\u201327. https:\/\/doi.org\/10.1111\/BPH.13641","journal-title":"Br J Pharmacol"},{"key":"10194_CR111","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2020.114385","author":"P Pelegrin","year":"2021","unstructured":"Pelegrin P (2021) P2X7 receptor and the NLRP3 inflammasome: partners in crime. Biochem Pharmacol. https:\/\/doi.org\/10.1016\/j.bcp.2020.114385","journal-title":"Biochem Pharmacol"},{"key":"10194_CR112","doi-asserted-by":"publisher","first-page":"1340405","DOI":"10.3389\/FIMMU.2024.1340405\/FULL","volume":"15","author":"JR Yaron","year":"2024","unstructured":"Yaron JR, Bakkaloglu S, Grigaitis NA, Babur FH, Macko S, Rhodes S et al (2024) Inflammasome modulation with P2X7 inhibitor A438079-loaded dressings for diabetic wound healing. Front Immunol 15:1340405. https:\/\/doi.org\/10.3389\/FIMMU.2024.1340405\/FULL","journal-title":"Front Immunol"},{"key":"10194_CR113","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1136\/annrheumdis-2011-143578","volume":"71","author":"EC Keystone","year":"2012","unstructured":"Keystone EC, Wang MM, Layton M, Hollis S, McInnes IB (2012) Clinical evaluation of the efficacy of the P2X7 purinergic receptor antagonist AZD9056 on the signs and symptoms of rheumatoid arthritis in patients with active disease despite treatment with methotrexate or sulphasalazine. Ann Rheum Dis 71:1630\u20131635. https:\/\/doi.org\/10.1136\/annrheumdis-2011-143578","journal-title":"Ann Rheum Dis"},{"key":"10194_CR114","doi-asserted-by":"publisher","first-page":"720","DOI":"10.3899\/JRHEUM.110874","volume":"39","author":"TC Stock","year":"2012","unstructured":"Stock TC, Bloom BJ, Wei N, Ishaq S, Park W, Wang X et al (2012) Efficacy and safety of CE-224,535, an antagonist of P2X7 receptor, in treatment of patients with rheumatoid arthritis inadequately controlled by methotrexate. J Rheumatol 39:720\u2013727. https:\/\/doi.org\/10.3899\/JRHEUM.110874","journal-title":"J Rheumatol"},{"key":"10194_CR115","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/S11302-020-09692-4","volume":"16","author":"D Ly","year":"2020","unstructured":"Ly D, Dongol A, Cuthbertson P, Guy TV, Geraghty NJ, Sophocleous RA et al (2020) The P2X7 receptor antagonist JNJ-47965567 administered thrice weekly from disease onset does not alter progression of amyotrophic lateral sclerosis in SOD1G93A mice. Purinergic Signal 16:109. https:\/\/doi.org\/10.1007\/S11302-020-09692-4","journal-title":"Purinergic Signal"},{"key":"10194_CR116","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.neuropharm.2014.01.045","volume":"81","author":"MRS Carmo","year":"2014","unstructured":"Carmo MRS, Menezes APF, Nunes ACL, Pli\u00e1ssova A, Rolo AP, Palmeira CM et al (2014) The P2X7 receptor antagonist Brilliant Blue G attenuates contralateral rotations in a rat model of Parkinsonism through a combined control of synaptotoxicity, neurotoxicity and gliosis. Neuropharmacology 81:142\u2013152. https:\/\/doi.org\/10.1016\/j.neuropharm.2014.01.045","journal-title":"Neuropharmacology"},{"key":"10194_CR117","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/J.1365-2125.2012.04320.X","volume":"75","author":"Z Ali","year":"2012","unstructured":"Ali Z, Laurijssens B, Ostenfeld T, Mchugh S, Stylianou A, Scott-Stevens P et al (2012) Pharmacokinetic and pharmacodynamic profiling of a P2X7 receptor allosteric modulator GSK1482160 in healthy human subjects. Br J Clin Pharmacol 75:197. https:\/\/doi.org\/10.1111\/J.1365-2125.2012.04320.X","journal-title":"Br J Clin Pharmacol"},{"key":"10194_CR118","doi-asserted-by":"publisher","DOI":"10.1002\/ADVS.202300521","author":"AJ Grant","year":"2023","unstructured":"Grant AJ, Yang N, Moore MJ, Lam YT, Michael PL, Chan AHP et al (2023) Selective NLRP3 inflammasome inhibitor MCC950 suppresses inflammation and facilitates healing in vascular materials. Adv Sci (Weinh). https:\/\/doi.org\/10.1002\/ADVS.202300521","journal-title":"Adv Sci (Weinh)"},{"key":"10194_CR119","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/J.1471-4159.2009.06435.X","volume":"112","author":"SS Kamboj","year":"2010","unstructured":"Kamboj SS, Vasishta RK, Sandhir R (2010) N-acetylcysteine inhibits hyperglycemia-induced oxidative stress and apoptosis markers in diabetic neuropathy. J Neurochem 112:77\u201391. https:\/\/doi.org\/10.1111\/J.1471-4159.2009.06435.X","journal-title":"J Neurochem"},{"key":"10194_CR120","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3390\/NU18020313","volume":"18","author":"\u0141 Kogut","year":"2026","unstructured":"Kogut \u0141, Puchalski C, Katry\u0144ska D, Zagu\u0142a G (2026) The multidirectional biological activity of resveratrol: molecular mechanisms, systemic effects and therapeutic potential\u2014a review. Nutrients 18:313. https:\/\/doi.org\/10.3390\/NU18020313","journal-title":"Nutrients"},{"key":"10194_CR121","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1210\/ENDREV\/BNAB027","volume":"43","author":"ENC Manoogian","year":"2021","unstructured":"Manoogian ENC, Chow LS, Taub PR, Laferr\u00e8re B, Panda S (2021) Time-restricted eating for the prevention and management of metabolic diseases. Endocr Rev 43:405. https:\/\/doi.org\/10.1210\/ENDREV\/BNAB027","journal-title":"Endocr Rev"},{"key":"10194_CR122","doi-asserted-by":"publisher","first-page":"1","DOI":"10.33069\/CIM.2023.0006","volume":"5","author":"HJ Lee","year":"2023","unstructured":"Lee HJ (2023) Importance of circadian rhythm in drug administration timing. Chronobiol Med 5:1\u20132. https:\/\/doi.org\/10.33069\/CIM.2023.0006","journal-title":"Chronobiol Med"},{"key":"10194_CR123","doi-asserted-by":"publisher","first-page":"4197","DOI":"10.1016\/J.BMCL.2015.08.004","volume":"25","author":"SM Lee","year":"2015","unstructured":"Lee SM, Cho JH, Lee SD, Kim YC (2015) Nanoparticle-encapsulated P2X\u2087 receptor antagonist in a pH-sensitive polymer as a potential local drug delivery system to acidic inflammatory environments. Bioorg Med Chem Lett 25:4197\u20134202. https:\/\/doi.org\/10.1016\/J.BMCL.2015.08.004","journal-title":"Bioorg Med Chem Lett"},{"key":"10194_CR124","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS262110445","volume":"26","author":"IM Crasan","year":"2025","unstructured":"Crasan IM, Tanase M, Delia CE, Gradisteanu-Pircalabioru G, Cimpean A, Ionica E (2025) Metaflammation\u2019s role in systemic dysfunction in obesity: a comprehensive review. Int J Mol Sci 26:10445. https:\/\/doi.org\/10.3390\/IJMS262110445","journal-title":"Int J Mol Sci"},{"key":"10194_CR125","doi-asserted-by":"publisher","DOI":"10.1016\/J.ECOENV.2026.120111","volume":"316","author":"B Yang","year":"2026","unstructured":"Yang B, Shi G, Zhao L, Tuerxunaili L, Asihaer W, Song M et al (2026) Blue light exposure exacerbates obesity in high-fat diet-fed mice by inducing mitochondrial dysfunction in the white adipose tissue. Ecotoxicol Environ Saf 316:120111. https:\/\/doi.org\/10.1016\/J.ECOENV.2026.120111","journal-title":"Ecotoxicol Environ Saf"},{"key":"10194_CR126","doi-asserted-by":"publisher","DOI":"10.1210\/ENDOCR\/BQAD019","author":"M Asano","year":"2023","unstructured":"Asano M, Kajita K, Fuwa M, Kajita T, Mori I, Akahoshi N et al (2023) Opposing roles of sphingosine 1-phosphate receptors 1 and 2 in fat deposition and glucose tolerance in obese male mice. Endocrinology. https:\/\/doi.org\/10.1210\/ENDOCR\/BQAD019","journal-title":"Endocrinology"},{"key":"10194_CR127","doi-asserted-by":"publisher","DOI":"10.1155\/IJHY\/8882980","volume":"2025","author":"A Li","year":"2025","unstructured":"Li A, Chen X, Huang WK, Li N, Zhu L, Shao G (2025) Transcriptome-based identification of biomarkers associated with sphingosine-1-phosphate signaling pathway in aortic dissection. Int J Hypertens 2025:8882980. https:\/\/doi.org\/10.1155\/IJHY\/8882980","journal-title":"Int J Hypertens"},{"key":"10194_CR128","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1038\/NM.2250","volume":"16","author":"H Lee","year":"2010","unstructured":"Lee H, Deng J, Kujawski M, Yang C, Liu Y, Herrmann A et al (2010) STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors. Nat Med 16:1421\u20131428. https:\/\/doi.org\/10.1038\/NM.2250","journal-title":"Nat Med"},{"key":"10194_CR129","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1186\/S12964-023-01356-1","volume":"21","author":"J Bockstiegel","year":"2023","unstructured":"Bockstiegel J, Engelhardt J, Weindl G (2023) P2X7 receptor activation leads to NLRP3-independent IL-1\u03b2 release by human macrophages. Cell Commun Signal 21:335. https:\/\/doi.org\/10.1186\/S12964-023-01356-1","journal-title":"Cell Commun Signal"},{"key":"10194_CR130","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS252313190","volume":"25","author":"DK Vo","year":"2024","unstructured":"Vo DK, Trinh KTL (2024) Emerging biomarkers in metabolomics: advancements in precision health and disease diagnosis. Int J Mol Sci 25:13190. https:\/\/doi.org\/10.3390\/IJMS252313190","journal-title":"Int J Mol Sci"},{"key":"10194_CR131","doi-asserted-by":"publisher","DOI":"10.1186\/S13046-022-02589-7","volume":"42","author":"X Wang","year":"2023","unstructured":"Wang X, Guo W, Shi X, Chen Y, Yu Y, Du B et al (2023) S1PR1\/S1PR3-YAP signaling and S1P-ALOX15 signaling contribute to an aggressive behavior in obesity-lymphoma. J Exp Clin Cancer Res 42:3. https:\/\/doi.org\/10.1186\/S13046-022-02589-7","journal-title":"J Exp Clin Cancer Res"},{"key":"10194_CR132","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1248\/BPB.33.159","volume":"33","author":"S Ohdo","year":"2010","unstructured":"Ohdo S (2010) Chronopharmaceutics: pharmaceutics focused on biological rhythm. Biol Pharm Bull 33:159\u2013167. https:\/\/doi.org\/10.1248\/BPB.33.159","journal-title":"Biol Pharm Bull"},{"key":"10194_CR133","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3390\/BIOLOGY12020301","volume":"12","author":"A Tiwari","year":"2023","unstructured":"Tiwari A, Rathor P, Trivedi PK, Ch R (2023) Multi-omics reveal interplay between circadian dysfunction and type2 diabetes. Biology (Basel) 12:301. https:\/\/doi.org\/10.3390\/BIOLOGY12020301","journal-title":"Biology (Basel)"},{"key":"10194_CR134","doi-asserted-by":"publisher","first-page":"31981","DOI":"10.1039\/D5RA04137F","volume":"15","author":"M Zeeshan","year":"2025","unstructured":"Zeeshan M, Hu J, Mao CX, Danish A, Xiong Y, Irshad MS et al (2025) Nanomaterial-enabled drug delivery systems for circadian medicine: bridging direct rhythm modulation and chronotherapy. RSC Adv 15:31981. https:\/\/doi.org\/10.1039\/D5RA04137F","journal-title":"RSC Adv"},{"key":"10194_CR135","doi-asserted-by":"publisher","first-page":"3438","DOI":"10.1021\/ACS.BIOMAC.3C00388","volume":"24","author":"RC Tang","year":"2023","unstructured":"Tang RC, Yang IH, Lin FH (2023) Current role and potential of polymeric biomaterials in clinical obesity treatment. Biomacromol 24:3438\u20133449. https:\/\/doi.org\/10.1021\/ACS.BIOMAC.3C00388","journal-title":"Biomacromol"},{"key":"10194_CR136","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2217\/NNM-2022-0261","volume":"18","author":"F Athanasopoulou","year":"2023","unstructured":"Athanasopoulou F, Manolakakis M, Vernia S, Kamaly N (2023) Nanodrug delivery systems for metabolic chronic liver diseases: advances and perspectives. Nanomedicine (Lond) 18:67\u201384. https:\/\/doi.org\/10.2217\/NNM-2022-0261","journal-title":"Nanomedicine (Lond)"}],"container-title":["Purinergic Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11302-026-10194-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11302-026-10194-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11302-026-10194-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:02:30Z","timestamp":1792522950000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11302-026-10194-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,20]]},"references-count":136,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["10194"],"URL":"https:\/\/doi.org\/10.1007\/s11302-026-10194-y","relation":{},"ISSN":["1573-9538","1573-9546"],"issn-type":[{"value":"1573-9538","type":"print"},{"value":"1573-9546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,20]]},"assertion":[{"value":"19 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Compliance with ethical standards","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals\u00a0performed by any of the authors","order":3,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"80"}}